lymphoma and he is controlling his lymphoma with somatostatin
injections. He has no side effect, somatostatin has activity in
low grade lymphomas and is not myelotoxic.
See below for references
carla
Evaluation of a somatostatin analog in the treatment of
lymphoproliferative disorders: results of a phase II North Central
Cancer Treatment Group trial.Witzig TE, Letendre L, Gerstner J,
Schroeder G, Mailliard JA, Colon-Otero G, Marschke RF, Windschitl HE.
Mayo Clinic, Rochester, MN 55905, USA.
4: Related Articles, LinksFerone D, Hofland LJ, Colao A, Lamberts SW,
van Hagen PM.
Neuroendocrine aspects of immunolymphoproliferative diseases.
Ann Oncol. 2001;12 Suppl 2:S125-30. Review.
PMID: 11762338 [PubMed - indexed for MEDLINE
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/cancercured/
<*> Your email settings:
Individual Email | Traditional
<*> To change settings online go to:
http://groups.yahoo.com/group/cancercured/join
(Yahoo! ID required)
<*> To change settings via email:
mailto:cancercured-digest@yahoogroups.com
mailto:cancercured-fullfeatured@yahoogroups.com
<*> To unsubscribe from this group, send an email to:
cancercured-unsubscribe@yahoogroups.com
<*> Your use of Yahoo! Groups is subject to:
Tidak ada komentar:
Posting Komentar